Table 4.
Prediction performance for the 6 clinical T1DM subjects
| Subject | 559 | 563 | 570 | 575 | 588 | 591 | Avg ± SD |
|---|---|---|---|---|---|---|---|
| DRNN | |||||||
| RMSE (mg/dl) | 18.6 | 18.0 | 15.3 | 22.7 | 17.6 | 21.1 | 18.9 ± 2.6 |
| MARD (%) | 8.6 | 8.0 | 5.6 | 10.3 | 7.9 | 11.9 | 8.7 ± 2.2 |
| τlag (mins) | 4.8 | 6.3 | 2.2 | 12.3 | 8.6 | 14.1 | 8.1 ± 4.1 |
| NNPG | |||||||
| RMSE (mg/dl) | 23.3 | 21.2 | 19.0 | 27.4 | 21.9 | 24.9 | 22.9 ± 2.9∗∗ |
| MARD (%) | 10.2 | 9.4 | 7.1 | 13.4 | 9.7 | 14.8 | 10.8 ± 2.8∗∗ |
| τlag (mins) | 12.8 | 16.4 | 11.8 | 21.4 | 13.6 | 22.6 | 16.4 ± 4.2∗∗ |
| SVR | |||||||
| RMSE (mg/dl) | 23.5 | 18.3 | 20.4 | 23.6 | 20.6 | 23.5 | 21.7 ± 1.9∗ |
| MARD (%) | 9.8 | 8.3 | 6.2 | 10.2 | 8.4 | 12.6 | 9.2 ± 2.2∗ |
| τlag (mins) | 11.4 | 15.8 | 10.3 | 20.4 | 12.3 | 21.4 | 15.3 ± 4.3∗∗ |
| ARX | |||||||
| RMSE (mg/dl) | 18.7 | 19.6 | 16.8 | 23.6 | 19.5 | 22.4 | 20.1 ± 2.5∗ |
| MARD (%) | 8.0 | 8.4 | 6.0 | 10.6 | 8.3 | 12.0 | 8.9 ± 4.0 |
| τlag (mins) | 8.4 | 13.4 | 8.6 | 18.1 | 11.8 | 21.3 | 13.6 ± 4.8∗∗ |
∗p ≤ 0.05 ∗∗p ≤ 0.01